
Your Action Needed: NYC Proposes Regulatory Author...
Help us move legislation forward to assign regulatory authority of New York City indoor tanning facilities to the NYC Department of Health.
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Help us move legislation forward to assign regulatory authority of New York City indoor tanning facilities to the NYC Department of Health.
Our National Director of Volunteer Services, Mary Antonucci, writes: “How’s this for a business strategy— take the fact some women tend to suffer from low self-es...
The Melanoma Research Foundation’s CURE Ocular Melanoma Initiative Announces New Research Grant Recipients and Celebrates Two-Year Anniversary
Actor and comedian Kevin Nealon will reprise his role as host of the second annual Celebrity Golf Classic to fuel melanoma research on November 18th at the Lakeside Golf Cl...
For the first time in 2 decades, the U.S. government has shut down. Media have focused a great deal of attention on the closure of national parks and restrictions to vetera...
Philadelphia-Area Advocates Inaugurate Wings of Hope for Melanoma Gala to Support Research for a Cure
Pale Girl SPEAKS’ Hillary Fogelson shares tips for teaching important sunscreen habits in time for the new school year.
On Tuesday, the Senate Defense Appropriations Subcommittee Chair, Sen. Richard Durbin (D-Ill.), announced the Subcommittee’s recommendation for a $25 million allocati...
Act now! Public comments are now being accepted in response to the FDA’s proposal to reclassify tanning beds.
EHE International Supports the SHADE Foundation of America and the Melanoma Research Foundation to Raise Awareness for Skin Cancer and Specifically Melanoma
BREAKING: combining ipilimumab & nivolumab may result in improved outcomes for people with advanced melanoma
On Wednesday, May 29, 2013, the FDA approved two new drugs for metastatic melanoma, a BRAF inhibitor and a MEK inhibitor. Liz Szabo, reporter for USA TODAY, interviewed the...
Oct 16, 2025 ET
Oct 30, 2025 ET